AHR | Aryl hydrocarbon receptor | Cancer-related genes Transcription factors
| | | | | Expressed in all |
ARNT | Aryl hydrocarbon receptor nuclear translocator | Cancer-related genes Transcription factors
| | | | | Expressed in all |
ARNTL | Aryl hydrocarbon receptor nuclear translocator-like | Predicted secreted proteins Transcription factors
| | | | | Expressed in all |
ARNTL2 | Aryl hydrocarbon receptor nuclear translocator-like 2 | Transcription factors
| | | | | Tissue enhanced |
ATF1 | Activating transcription factor 1 | Cancer-related genes Disease related genes Transcription factors
| | | | | Expressed in all |
ATF2 | Activating transcription factor 2 | Enzymes Transcription factors
| | | | | Expressed in all |
ATF3 | Activating transcription factor 3 | Transcription factors
| | | | | Expressed in all |
ATF4 | Activating transcription factor 4 | Transcription factors
| | | | | Expressed in all |
ATF5 | Activating transcription factor 5 | Transcription factors
| | | | | Group enriched |
BACH1 | BTB and CNC homology 1, basic leucine zipper transcription factor 1 | Plasma proteins Transcription factors
| | | | | Expressed in all |
BHLHA15 | Basic helix-loop-helix family, member a15 | Transcription factors
| | | | | Group enriched |
BHLHE22 | Basic helix-loop-helix family, member e22 | Transcription factors
| | | | | Tissue enhanced |
BHLHE40 | Basic helix-loop-helix family, member e40 | Transcription factors
| | | | | Expressed in all |
CEBPB | CCAAT/enhancer binding protein (C/EBP), beta | Transcription factors
| | | | | Expressed in all |
CEBPE | CCAAT/enhancer binding protein (C/EBP), epsilon | Transcription factors
| | | | | Tissue enriched |
CEBPG | CCAAT/enhancer binding protein (C/EBP), gamma | Transcription factors
| | | | | Expressed in all |
CLOCK | Clock circadian regulator | Enzymes Transcription factors
| | | | | Expressed in all |
CREB1 | CAMP responsive element binding protein 1 | Cancer-related genes Disease related genes Transcription factors
| | | | | Expressed in all |
CREB3L1 | CAMP responsive element binding protein 3-like 1 | Cancer-related genes Predicted membrane proteins Transcription factors
| | | | | Mixed |
CREBZF | CREB/ATF bZIP transcription factor | Transcription factors
| | | | | Expressed in all |
CREM | CAMP responsive element modulator | Transcription factors
| | | | | Expressed in all |
DDIT3 | DNA-damage-inducible transcript 3 | Cancer-related genes Disease related genes Transcription factors
| | | | | Expressed in all |
FOS | FBJ murine osteosarcoma viral oncogene homolog | Cancer-related genes Transcription factors
| | | | | Expressed in all |
FOSL1 | FOS-like antigen 1 | Cancer-related genes Plasma proteins Transcription factors
| | | | | Tissue enhanced |
FOSL2 | FOS-like antigen 2 | Transcription factors
| | | | | Expressed in all |
HAND2 | Heart and neural crest derivatives expressed 2 | Transcription factors
| | | | | Mixed |
HES1 | Hes family bHLH transcription factor 1 | Plasma proteins Transcription factors
| | | | | Mixed |
HES2 | Hes family bHLH transcription factor 2 | Transcription factors
| | | | | Tissue enhanced |
HIF1A | Hypoxia inducible factor 1, alpha subunit (basic helix-loop-helix transcription factor) | Cancer-related genes Plasma proteins Transcription factors
| | | | | Expressed in all |
ID1 | Inhibitor of DNA binding 1, dominant negative helix-loop-helix protein | Cancer-related genes Plasma proteins Predicted secreted proteins Transcription factors
| | | | | Expressed in all |
ID2 | Inhibitor of DNA binding 2, dominant negative helix-loop-helix protein | Cancer-related genes Transcription factors
| | | | | Expressed in all |
ID3 | Inhibitor of DNA binding 3, dominant negative helix-loop-helix protein | Cancer-related genes Transcription factors
| | | | | Expressed in all |
JDP2 | Jun dimerization protein 2 | Transcription factors
| | | | | Expressed in all |
JUN | Jun proto-oncogene | Cancer-related genes FDA approved drug targets Transcription factors
| | | | | Expressed in all |
JUNB | Jun B proto-oncogene | Plasma proteins Transcription factors
| | | | | Expressed in all |
JUND | Jun D proto-oncogene | Cancer-related genes Plasma proteins Transcription factors
| | | | | Expressed in all |
MAF | V-maf avian musculoaponeurotic fibrosarcoma oncogene homolog | Cancer-related genes Disease related genes Transcription factors
| | | | | Mixed |
MAFK | V-maf avian musculoaponeurotic fibrosarcoma oncogene homolog K | Transcription factors
| | | | | Expressed in all |
MAX | MYC associated factor X | Cancer-related genes Transcription factors
| | | | | Expressed in all |
MGA | MGA, MAX dimerization protein | Cancer-related genes Transcription factors
| | | | | Expressed in all |
MITF | Microphthalmia-associated transcription factor | Cancer-related genes Disease related genes Transcription factors
| | | | | Expressed in all |
MLXIP | MLX interacting protein | Mitochondrial proteins Predicted secreted proteins Transcription factors
| | | | | Expressed in all |
MNT | MAX network transcriptional repressor | Transcription factors
| | | | | Expressed in all |
MXD1 | MAX dimerization protein 1 | Transcription factors
| | | | | Expressed in all |
MXD4 | MAX dimerization protein 4 | Transcription factors
| | | | | Expressed in all |
MXI1 | MAX interactor 1, dimerization protein | Cancer-related genes Disease related genes Transcription factors
| | | | | Expressed in all |
MYC | V-myc avian myelocytomatosis viral oncogene homolog | Cancer-related genes Disease related genes Transcription factors
| | | | | Expressed in all |
MYF5 | Myogenic factor 5 | Transcription factors
| | | | | Tissue enhanced |
MYOD1 | Myogenic differentiation 1 | Cancer-related genes Transcription factors
| | | | | Tissue enriched |
NCOA1 | Nuclear receptor coactivator 1 | Cancer-related genes Disease related genes Enzymes Potential drug targets Transcription factors
| | | | | Expressed in all |